Table 1.
Baseline characteristics of PLWH.
| Characteristics (n = 15) | Mean (SD) or n (%) |
|---|---|
| Age, yrs | 50 (6.9) |
|
| |
| Gender | |
| Male | 13 (86.7%) |
|
| |
| Race and ethnicity | |
| Black | 7 (46.7%) |
| Hispanic white | 6 (40.0%) |
| Non-Hispanic white | 2 (13.3%) |
|
| |
| Self-identified major source of HIV infection | |
| MSM | 9 (60.0%) |
| Heterosexual sex | 5 (33.3%) |
| IV drug use | 1 (6.7%) |
|
| |
| Duration since HIV diagnosis, yrs | 16 (7.0) |
|
| |
| Most recent CD4 count, cells/uL (min, max) | 774.2 (275, 1375) |
|
| |
| Most recent plasma HIV RNA | |
| Undetectable (<20 copies/mL) | 10 (66.7%) |
| Detectable (≥20 copies/mL) | 4 (26.7%) |
| Unknown | 1 (6.7%) |
|
| |
| Self-reported missed doses in the past month∗ | |
| 0 | 3 (20%) |
| 1-2 | 3 (20%) |
| >2 | 5 (33.3%) |
| Unknown | 4 (26.7%) |
|
| |
| Missed clinic visits in the past 6 months | |
| None | 8 (53.3%) |
| 1 | 2 (13.3%) |
| >1 | 3 (20%) |
| Unknown | 2 (13.3%) |
∗All patients were on one pill once-daily ARV regimens. SD, standard deviation; MSM, men who have sex with men; HIV, human immunodeficiency virus; IV, intravenous; ARV, antiretroviral; PLWH, people living with HIV.